The FDA’s refusal to review marketing plans was error and not harmless (disagreeing with Fifth and DC Circuits).Read More
Tags :FDA
The FDA’s refusal to review marketing plans was error and not harmless (disagreeing with Fifth and DC Circuits).Read More
These studies inform product application reviews. Read More
EAS suggests areas of focus for the Reagan-Udall experts evaluating the center.Read More
The FDA veteran had been on leave while exploring private-sector opportunities.Read More
The e-cigarette manufacturer waited too long to file its emergency motion, says court.Read More
The move follows favorable product reception in the United Kingdom. Read More
The announcement comes as FDA Commissioner Robert Califf attempts to push past several controversies.Read More
The Fifth Circuit denied the companies' requests Monday for review of the agency’s orders.Read More
A spokesperson for Juul Labs told Reuters that the company is looking at options to protect its business.Read More
